Amedisys Stock Short Ratio

AMED Stock  USD 92.16  0.30  0.32%   
Amedisys fundamentals help investors to digest information that contributes to Amedisys' financial success or failures. It also enables traders to predict the movement of Amedisys Stock. The fundamental analysis module provides a way to measure Amedisys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amedisys stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Amedisys Short Ratio Analysis

Amedisys' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
 2021 2022 2023 2024 (projected)
Gross Profit980.8M962.8M457.1M447.4M
Total Revenue2.2B2.2B2.2B2.3B

Short Ratio

 = 

Short Interest

Average Trading Volume

More About Short Ratio | All Equity Analysis

Current Amedisys Short Ratio

    
  9.23 X  
Most of Amedisys' fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amedisys is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Amedisys Short Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Amedisys is extremely important. It helps to project a fair market value of Amedisys Stock properly, considering its historical fundamentals such as Short Ratio. Since Amedisys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Amedisys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Amedisys' interrelated accounts and indicators.
-0.340.990.90.950.60.950.72-0.090.990.950.90.760.530.70.510.94-0.92-0.240.980.89-0.810.290.880.850.40.720.80.91-0.640.81
-0.34-0.36-0.48-0.41-0.42-0.28-0.350.16-0.31-0.2-0.24-0.44-0.15-0.3-0.08-0.430.410.22-0.39-0.420.37-0.17-0.33-0.33-0.22-0.48-0.08-0.480.07-0.06
0.99-0.360.860.930.640.970.75-0.030.970.950.880.760.580.670.470.92-0.9-0.240.970.88-0.750.270.840.850.350.710.790.88-0.620.79
0.9-0.480.860.90.560.780.68-0.270.910.740.830.630.370.530.450.98-0.88-0.170.920.91-0.870.340.90.760.50.760.620.94-0.560.65
0.95-0.410.930.90.470.870.66-0.390.940.850.870.810.290.760.570.94-0.95-0.370.980.88-0.920.490.940.810.630.780.810.95-0.660.84
0.6-0.420.640.560.470.660.430.370.580.560.430.130.780.250.430.52-0.59-0.050.570.72-0.330.070.260.690.060.310.080.51-0.60.17
0.95-0.280.970.780.870.660.640.040.930.980.840.70.610.620.450.84-0.88-0.30.920.84-0.680.340.760.860.340.660.760.8-0.640.76
0.72-0.350.750.680.660.430.640.10.670.630.630.560.450.330.220.75-0.560.030.690.68-0.48-0.070.650.530.00.570.550.65-0.230.51
-0.090.16-0.03-0.27-0.390.370.040.1-0.140.05-0.19-0.310.68-0.39-0.35-0.240.320.39-0.24-0.130.6-0.65-0.47-0.03-0.82-0.31-0.28-0.340.21-0.3
0.99-0.310.970.910.940.580.930.67-0.140.930.90.730.490.710.540.95-0.91-0.230.980.89-0.840.310.890.840.440.690.790.92-0.670.81
0.95-0.20.950.740.850.560.980.630.050.930.850.730.570.650.460.82-0.83-0.30.90.78-0.660.290.760.820.30.630.820.78-0.580.81
0.9-0.240.880.830.870.430.840.63-0.190.90.850.740.330.680.580.85-0.75-0.060.870.77-0.720.320.840.650.360.610.80.83-0.490.81
0.76-0.440.760.630.810.130.70.56-0.310.730.730.740.160.750.220.71-0.68-0.40.760.56-0.660.270.810.590.370.750.90.74-0.220.85
0.53-0.150.580.370.290.780.610.450.680.490.570.330.160.090.010.39-0.420.120.420.57-0.08-0.250.140.67-0.260.340.170.36-0.360.28
0.7-0.30.670.530.760.250.620.33-0.390.710.650.680.750.090.610.59-0.68-0.490.730.51-0.710.40.680.590.550.370.730.69-0.620.77
0.51-0.080.470.450.570.430.450.22-0.350.540.460.580.220.010.610.44-0.51-0.160.550.53-0.590.40.450.380.470.120.320.51-0.670.39
0.94-0.430.920.980.940.520.840.75-0.240.950.820.850.710.390.590.44-0.89-0.230.960.91-0.880.330.950.790.470.790.740.96-0.540.74
-0.920.41-0.9-0.88-0.95-0.59-0.88-0.560.32-0.91-0.83-0.75-0.68-0.42-0.68-0.51-0.890.42-0.96-0.890.89-0.52-0.85-0.9-0.68-0.76-0.68-0.910.78-0.74
-0.240.22-0.24-0.17-0.37-0.05-0.30.030.39-0.23-0.3-0.06-0.40.12-0.49-0.16-0.230.42-0.34-0.190.45-0.54-0.35-0.41-0.61-0.25-0.37-0.30.36-0.37
0.98-0.390.970.920.980.570.920.69-0.240.980.90.870.760.420.730.550.96-0.96-0.340.91-0.890.40.920.860.540.750.790.95-0.680.81
0.89-0.420.880.910.880.720.840.68-0.130.890.780.770.560.570.510.530.91-0.89-0.190.91-0.820.340.810.90.430.790.580.94-0.630.68
-0.810.37-0.75-0.87-0.92-0.33-0.68-0.480.6-0.84-0.66-0.72-0.66-0.08-0.71-0.59-0.880.890.45-0.89-0.82-0.57-0.93-0.73-0.78-0.71-0.69-0.930.66-0.73
0.29-0.170.270.340.490.070.34-0.07-0.650.310.290.320.27-0.250.40.40.33-0.52-0.540.40.34-0.570.440.370.810.330.320.41-0.50.33
0.88-0.330.840.90.940.260.760.65-0.470.890.760.840.810.140.680.450.95-0.85-0.350.920.81-0.930.440.710.590.790.850.94-0.470.85
0.85-0.330.850.760.810.690.860.53-0.030.840.820.650.590.670.590.380.79-0.9-0.410.860.9-0.730.370.710.460.750.620.85-0.710.73
0.4-0.220.350.50.630.060.340.0-0.820.440.30.360.37-0.260.550.470.47-0.68-0.610.540.43-0.780.810.590.460.440.370.55-0.660.45
0.72-0.480.710.760.780.310.660.57-0.310.690.630.610.750.340.370.120.79-0.76-0.250.750.79-0.710.330.790.750.440.660.82-0.250.71
0.8-0.080.790.620.810.080.760.55-0.280.790.820.80.90.170.730.320.74-0.68-0.370.790.58-0.690.320.850.620.370.660.74-0.320.95
0.91-0.480.880.940.950.510.80.65-0.340.920.780.830.740.360.690.510.96-0.91-0.30.950.94-0.930.410.940.850.550.820.74-0.580.79
-0.640.07-0.62-0.56-0.66-0.6-0.64-0.230.21-0.67-0.58-0.49-0.22-0.36-0.62-0.67-0.540.780.36-0.68-0.630.66-0.5-0.47-0.71-0.66-0.25-0.32-0.58-0.45
0.81-0.060.790.650.840.170.760.51-0.30.810.810.810.850.280.770.390.74-0.74-0.370.810.68-0.730.330.850.730.450.710.950.79-0.45
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Competition

Amedisys Discontinued Operations

Discontinued Operations

(260,820)

At present, Amedisys' Discontinued Operations is projected to increase significantly based on the last few years of reporting.
Based on the latest financial disclosure, Amedisys has a Short Ratio of 9.23 times. This is 136.67% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The short ratio for all United States stocks is 130.75% lower than that of the firm.

Amedisys Short Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amedisys' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amedisys could also be used in its relative valuation, which is a method of valuing Amedisys by comparing valuation metrics of similar companies.
Amedisys is currently under evaluation in short ratio category among related companies.

Amedisys Institutional Holders

Institutional Holdings refers to the ownership stake in Amedisys that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Amedisys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Amedisys' value.
Shares
Melqart Asset Management (uk) Ltd.2023-12-31
653.8 K
Magnetar Financial Llc2023-12-31
618.9 K
Alliancebernstein L.p.2023-12-31
545.1 K
Geode Capital Management, Llc2023-12-31
527.5 K
Dimensional Fund Advisors, Inc.2023-12-31
511.6 K
Cresset Asset Management, Llc2023-12-31
454.4 K
Van Lanschot Kempen Investment Management Nv2023-12-31
451.2 K
Woodline Partners Lp2023-12-31
446.7 K
Marshall Wace Asset Management Ltd2023-12-31
406.6 K
Vanguard Group Inc2023-12-31
3.2 M
Blackrock Inc2023-12-31
M

Amedisys Fundamentals

About Amedisys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Amedisys's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amedisys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amedisys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Amedisys operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 21000 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amedisys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amedisys' short interest history, or implied volatility extrapolated from Amedisys options trading.

Pair Trading with Amedisys

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amedisys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedisys will appreciate offsetting losses from the drop in the long position's value.

Moving against Amedisys Stock

  0.83PNTG Pennant Group Financial Report 2nd of May 2024 PairCorr
  0.79BSX Boston Scientific Corp Financial Report 24th of April 2024 PairCorr
  0.76EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.74MDWD Mediwound Downward RallyPairCorr
  0.64A Agilent Technologies Earnings Call TodayPairCorr
The ability to find closely correlated positions to Amedisys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amedisys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amedisys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amedisys to buy it.
The correlation of Amedisys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amedisys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amedisys moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amedisys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out Amedisys Piotroski F Score and Amedisys Altman Z Score analysis.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.30)
Revenue Per Share
68.603
Quarterly Revenue Growth
0.016
Return On Assets
0.0598
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.